本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Blueprint Medicines Corporation

84.86
+0.68000.81%
成交量:52.73万
成交额:4,459.27万
市值:54.23亿
市盈率:-79.51
高:85.41
开:84.50
低:83.55
收:84.18
数据加载中...
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/25

重要事件披露

Form 8-K - Current report
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities